AFS Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AFS Financial Group's BMY Position: Q4 2023 in Review
AFS Financial Group sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 6,016 shares — an estimated $349K sold.
AFS Financial Group first reported a position in BMY in Q4 2022 and held it in 4 quarters. The position peaked at $418K in Q4 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- AFS Financial Group reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
- AFS Financial Group sold 6,016 Bristol-Myers Squibb shares in Q4 2023, an estimated $349K.
- AFS Financial Group first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 4 quarters.
- AFS Financial Group's Bristol-Myers Squibb position peaked at $418K in Q4 2022.
- 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on AFS Financial Group's 13F filing for Q4 2023, filed 23 Jan 2024.